Literature DB >> 25514867

Cerebellar retraction and hearing loss after microvascular decompression for hemifacial spasm.

Min Ho Lee1, Hyun Seok Lee, Tae Keun Jee, Kyung Il Jo, Doo-Sik Kong, Jeong A Lee, Kwan Park.   

Abstract

BACKGROUND: This retrospective study evaluated the length of cerebellar retraction and the changes of intraoperative brainstem auditory evoked potential (BAEP) during microvascular decompression (MVD), and assessed the predictive value of the hearing loss as a prognostic indicator for the treatment outcome of hemifacial spasm (HFS).
METHODS: This series included 1,518 consecutive patients affected with HFS who underwent MVD, during which BAEP was monitored. Patients were divided into two groups based on whether hearing loss occurred following decompression or not. Each patient underwent a similar procedure performed by one neurosurgeon. The two patients groups were matched with regard to sex, age, and degree of spasm.
RESULTS: Among the 1,518 patients, 106 (6.98 %) displayed functional hearing changes. Hearing loss was permanent in 12 patients (0.79 %). Of the 1,412 patients with stationary hearing compared with preoperative audiometry, 96 patients were selected who were individually matched with respect to sex, age, and degree of spasm. BAEP changed immediately after cerebellar retraction in 7 of 12 hearing-loss patients, suggesting the importance of retraction on hearing outcomes. The distance from the cerebellar surface of the petrous temporal bone to the neurovascular compression point was measured. The median distance of cerebellar retraction in the hearing-loss group was 13.77 mm, which was longer than the median distance in the control group.
CONCLUSIONS: Preoperative measurement of the cerebellar retraction distance can be a valuable clue to predict and prevent postoperative hearing loss in MVD for HFS.

Entities:  

Mesh:

Year:  2014        PMID: 25514867     DOI: 10.1007/s00701-014-2301-8

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  7 in total

1.  Postoperative complications of microvascular decompression for hemifacial spasm: lessons from experience of 2040 cases.

Authors:  Min Ho Lee; Tae Keun Jee; Jeong Ah Lee; Kwan Park
Journal:  Neurosurg Rev       Date:  2015-09-18       Impact factor: 3.042

2.  Neurotologic Complications Following Microvascular Decompression: A Retrospective Study.

Authors:  Matthew Bartindale; Ayah Mohamed; Jason Bell; Matthew Kircher; Jacqueline Hill; Douglas Anderson; John Leonetti
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-14

3.  Hearing Outcomes after Microvascular Decompression for Hemifacial Spasm: An Institutional Experience.

Authors:  Ambuj Kumar; Ahmed Ansari; Yasuhiro Yamada; Tsukasa Kawase; Yoko Kato
Journal:  Asian J Neurosurg       Date:  2020-04-07

Review 4.  Hearing Loss following Posterior Fossa Microvascular Decompression: A Systematic Review.

Authors:  Matthew Bartindale; Matthew Kircher; William Adams; Neelam Balasubramanian; Jeffrey Liles; Jason Bell; John Leonetti
Journal:  Otolaryngol Head Neck Surg       Date:  2017-09-12       Impact factor: 3.497

5.  Long-term surgical results in microvascular decompression for hemifacial spasm: efficacy, morbidity and quality of life.

Authors:  M Montava; V Rossi; C L CurtoFais; J Mancini; J-P Lavieille
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-06       Impact factor: 2.124

6.  Microvascular decompression for typical trigeminal neuralgia: Personal experience with intraoperative neuromonitoring with level-specific-CE-Chirp® brainstem auditory evoked potentials in preventing possible hearing loss.

Authors:  Luciano Mastronardi; Franco Caputi; Guglielmo Cacciotti; Carlo Giacobbo Scavo; Raffaelino Roperto; Albert Sufianov
Journal:  Surg Neurol Int       Date:  2020-11-11

7.  Bioglue-Coated Teflon Sling Technique in Microvascular Decompression for Hemifacial Spasm Involving the Vertebral Artery.

Authors:  Seong Ho Lee; Jae Sung Park; Young Hwan Ahn
Journal:  J Korean Neurosurg Soc       Date:  2016-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.